Navigation Links
Today on Capitol Hill: The Malaria Forum
Date:4/21/2009

- Interdisciplinary team of experts joins forces to discuss the latest tools to combat this preventable but deadly disease -

BRIDGEWATER, N.J., April 21 /PRNewswire/ -- Today on Capitol Hill Congressmen Don Payne and John Boozman, co-chairs of the Congressional Malaria Caucus, join global pharmaceutical company sanofi-aventis and the non-profit Drugs for Neglected Disease initiative (DNDi) to host the Malaria Forum. The Malaria Forum offers an important opportunity to gain insights on health initiatives and partnerships that are focused on combating this dreaded disease worldwide.

Every year, as many as one million people die from malaria and another 300-500 million suffer from it. Malaria remains the leading cause of death for children under the age of five in Africa, and kills one child every 30 seconds worldwide.

The sanofi-aventis group has been present in Africa for decades and extensively in countries affected by malaria. In 2001, the Impact Malaria initiative, the first program from the sanofi-aventis Access to Medicines team was created mobilizing the company's expertise and resources to fight diseases including malaria.

DNDi, an independent, non-profit pharmaceutical research and development (R&D) organization, has been involved in developing and making available needs-adapted treatments for a group of deadly neglected diseases traditionally ignored by market-driven mechanisms for drug development. Since its founding in 2003, DNDi has already developed and made available two antimalarial medicines while reaching out in partnership to those in the remotest areas in Africa as well as the largest pharmaceutical companies in the world.

Dr. Francois Bompart, who is part of the sanofi-aventis group's Access to Medicine team, will discuss the importance of educating communities, healthcare professionals and families about malaria and adapting medicines to meet patient needs. "Our mission is to bring together all of sanofi-aventis' expertise in order to provide patients in developing countries with access to medicines and vaccines for specific diseases, such as malaria. However, based on the knowledge that medicines alone cannot solve all problems we are also involved in education, information and prevention initiatives in these countries. We are deeply committed to our continued efforts in promoting better health for patients worldwide and to satisfy unmet healthcare needs."

Hellen Gelband, a malaria expert and member of the Board of Directors of DNDi North America, will discuss the impact and needs of patients with neglected diseases like malaria, with a focus on how the medicine, ASAQ (artesunate-amodiaquine)(1) was developed in partnership with sanofi-aventis. In addition, Ms. Gelband will discuss why various types of partners, from the public and private sectors, are critical in addressing the global health imbalance and how DNDi is utilizing a wide array of partnerships in its patient-driven drug development model, which is already delivering concrete benefits to patients in the form of two new malaria drugs in use in the field.

The Malaria Forum will take place on Tuesday, April 21 from 3:00 PM - 4:30 PM at 2200 Rayburn House Office Building. It is not open to the public.

(1) ASAQ is not approved in the U.S.

About sanofi-aventis

Sanofi-aventis is a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients and their families. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). Sanofi-aventis U.S. is a U.S. affiliate of sanofi-aventis. For more information, visit www.sanofi-aventis.us or www.sanofi-aventis.com

US.COR.09.04.024

    Contact:
    Elizabeth Baxter - sanofi-aventis, +1-908-981-5360
    elizabeth.baxter@sanofi-aventis.com


'/>"/>
SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Good News for Tough Times: Small, Private University Responds to Todays Economic Challenges
2. City of Warrensville Heights Residents Have Access to Easy-to-Use Prescription Drug Discount Card Launched Today
3. TopBestPennyStocks.com Issues Technical Trade Alerts on Hot Stocks in the Market Today: CAST, VM, NFLX, PFE, AA, & COF
4. National Physicians Study: Nearly One Third Would Choose Different Career Today
5. Americas Egg Farmers to Participate in Annual White House Easter Egg Roll Today
6. Video: Davis Phinney Foundation and Medtronic Raise Awareness of How to Improve Your Life Today for Those Living With Parkinsons Disease
7. MedPage Today Pledges to Maintain and Expand News Coverage in 2009
8. Mayer Labs Acquires Today(R) Sponge Distribution Rights
9. National Public Health Week Begins Today With Launch of Viral Video Campaign
10. Rxonlinetoday Launch Cyber Shop for FDA Approved Medicines
11. Smokers Have Greater Incentive to Quit, as Big Tobacco Tax Hike Goes Into Effect Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... WHO: , Dr. Paul Thomas; Dr. ... , Medical doctors and PhD scientists will speak to the press on behalf of ... support of an independent vaccine safety commission. , WHERE: , Zenger Room, National ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, and ... high-quality results and maintaining GMP and USP compliance. In a new webinar from ... GMP requirements " these requirements are explained. The challenge is to determine ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... release of two biometric time and attendance tracking products: the new NCheck Cloud ... NCheck Cloud Bio Attendance uses biometric face recognition to enable users to check ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... plans work, the Self-Funding Success website has recently developed and published an informational ... Plans ” was created based on common inquiries the site’s team of third ...
(Date:3/28/2017)... ... 28, 2017 , ... A minimally invasive porcelain veneer is ... National Association of Dental Laboratories (NADL) is informing dentists about the benefits of ... utilizing dental laboratories and technicians that create these veneers. , According to ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  Medeon Biodesign, Inc., ... company, is pleased to announce that the Company ... of Panther Orthopedics, Inc., a San ... fixation solutions for orthopedic extremity applications.  ... expand rapidly, primarily due to procedure volume growth, ...
(Date:3/27/2017)... 2017 Summary This report ... Lilly and its partnering interests and activities since 2010. ... an in-depth insight into the partnering activity of one of ... company reports are prepared upon purchase to ensure inclusion of ... The report will be delivered in PDF format within ...
(Date:3/27/2017)... IRVINE, Calif. , March 27, 2017  Cryoport, ... announced that it intends to offer shares of common ... shelf registration statement on file with the Securities and ... market and other conditions, and there can be no ... be completed, or as to the actual size or ...
Breaking Medicine Technology: